| L1K | Name: | ~{N}-[1-(2-methyl-2-oxidanyl-propyl)benzimidazol-2-yl]-2-phenyl-pyridine-4-carboxamide | Formula: | C23 H22 N4 O2 | SMILES: | CC(C)(O)Cn1c(NC(=O)c2ccnc(c2)c3ccccc3)nc4ccccc14 | InChi: | InChI=1S/C23H22N4O2/c1-23(2,29)15-27-20-11-7-6-10-18(20)25-22(27)26-21(28)17-12-13-24-19(14-17)16-8-4-3-5-9-16/h3-14,29H,15H2,1-2H3,(H,25,26,28) | Definition date: | 2019-07-12 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | ~{N}-[1-(2-methyl-2-oxidanyl-propyl)benzimidazol-2-yl]-2-phenyl-pyridine-4-carboxamide |
|
| L3Z | Name: | 8-oxa-14,21,23,28-tetraazapentacyclo[23.3.1.02,7.014,22.015,20]nonacosa-1(28),2(7),3,5,15,17,19,21,25(29),26-decaen-24-one | Formula: | C24 H22 N4 O2 | SMILES: | O=C1Nc2nc3ccccc3n2CCCCCOc4ccccc4c5cc1ccn5 | InChi: | InChI=1S/C24H22N4O2/c29-23-17-12-13-25-20(16-17)18-8-2-5-11-22(18)30-15-7-1-6-14-28-21-10-4-3-9-19(21)26-24(28)27-23/h2-5,8-13,16H,1,6-7,14-15H2,(H,26,27,29) | Definition date: | 2019-07-19 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 |
|
| GZE | Name: | [4-[[4-chloranyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenyl] sulfamate | Formula: | C14 H11 Cl F3 N3 O4 S | SMILES: | N[S](=O)(=O)Oc1ccc(NC(=O)Nc2ccc(Cl)c(c2)C(F)(F)F)cc1 | InChi: | InChI=1S/C14H11ClF3N3O4S/c15-12-6-3-9(7-11(12)14(16,17)18)21-13(22)20-8-1-4-10(5-2-8)25-26(19,23)24/h1-7H,(H2,19,23,24)(H2,20,21,22) | Definition date: | 2018-10-26 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | [4-[[4-chloranyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenyl] sulfamate |
|
| GZH | Name: | 1-[4-chloranyl-3-(trifluoromethyl)phenyl]-3-[2-(4-sulfamoylphenyl)ethyl]urea | Formula: | C16 H15 Cl F3 N3 O3 S | SMILES: | N[S](=O)(=O)c1ccc(CCNC(=O)Nc2ccc(Cl)c(c2)C(F)(F)F)cc1 | InChi: | InChI=1S/C16H15ClF3N3O3S/c17-14-6-3-11(9-13(14)16(18,19)20)23-15(24)22-8-7-10-1-4-12(5-2-10)27(21,25)26/h1-6,9H,7-8H2,(H2,21,25,26)(H2,22,23,24) | Definition date: | 2018-10-26 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | 1-[4-chloranyl-3-(trifluoromethyl)phenyl]-3-[2-(4-sulfamoylphenyl)ethyl]urea |
|
| H0W | Name: | 6-chloranyl-3-[3-[(1~{S})-1-(4-chlorophenyl)ethyl]-5-phenyl-imidazol-4-yl]-~{N}-[2-[4-(2-oxidanylidene-1,3-oxazinan-3-yl)piperidin-1-yl]pyridin-3-yl]-1~{H}-indole-2-carboxamide | Formula: | C40 H37 Cl2 N7 O3 | SMILES: | C[CH](n1cnc(c2ccccc2)c1c3c([nH]c4cc(Cl)ccc34)C(=O)Nc5cccnc5N6CCC(CC6)N7CCCOC7=O)c8ccc(Cl)cc8 | InChi: | InChI=1S/C40H37Cl2N7O3/c1-25(26-10-12-28(41)13-11-26)49-24-44-35(27-7-3-2-4-8-27)37(49)34-31-15-14-29(42)23-33(31)45-36(34)39(50)46-32-9-5-18-43-38(32)47-20-16-30(17-21-47)48-19-6-22-52-40(48)51/h2-5,7-15,18,23-25,30,45H,6,16-17,19-22H2,1H3,(H,46,50)/t25-/m0/s1 | Definition date: | 2018-11-01 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | 6-chloranyl-3-[3-[(1~{S})-1-(4-chlorophenyl)ethyl]-5-phenyl-imidazol-4-yl]-~{N}-[2-[4-(2-oxidanylidene-1,3-oxazinan-3-yl)piperidin-1-yl]pyridin-3-yl]-1~{H}-indole-2-carboxamide |
|
| H3B | Name: | 3-trimethylsilylpropane-1-sulfonic acid | Formula: | C6 H16 O3 S Si | SMILES: | C[Si](C)(C)CCC[S](O)(=O)=O | InChi: | InChI=1S/C6H16O3SSi/c1-11(2,3)6-4-5-10(7,8)9/h4-6H2,1-3H3,(H,7,8,9) | Definition date: | 2018-11-12 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | 3-trimethylsilylpropane-1-sulfonic acid |
|
| K9V | Name: | N-{cis-4-[(2,6-difluorophenyl)methoxy]cyclohexyl}-N'-(3-phenylpropyl)urea | Formula: | C23 H28 F2 N2 O2 | SMILES: | c3ccc(CCCNC(=O)NC1CCC(CC1)OCc2c(F)cccc2F)cc3 | InChi: | InChI=1S/C23H28F2N2O2/c24-21-9-4-10-22(25)20(21)16-29-19-13-11-18(12-14-19)27-23(28)26-15-5-8-17-6-2-1-3-7-17/h1-4,6-7,9-10,18-19H,5,8,11-16H2,(H2,26,27,28)/t18-,19+ | Definition date: | 2018-11-16 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | N-{cis-4-[(2,6-difluorophenyl)methoxy]cyclohexyl}-N'-(3-phenylpropyl)urea |
|
| KC4 | Name: | N-methyl-4-{[trans-4-({[4-(trifluoromethoxy)phenyl]carbamoyl}amino)cyclohexyl]oxy}benzamide | Formula: | C22 H24 F3 N3 O4 | SMILES: | C2(CCC(NC(=O)Nc1ccc(cc1)OC(F)(F)F)CC2)Oc3ccc(C(NC)=O)cc3 | InChi: | InChI=1S/C22H24F3N3O4/c1-26-20(29)14-2-8-17(9-3-14)31-18-10-4-15(5-11-18)27-21(30)28-16-6-12-19(13-7-16)32-22(23,24)25/h2-3,6-9,12-13,15,18H,4-5,10-11H2,1H3,(H,26,29)(H2,27,28,30)/t15-,18- | Definition date: | 2018-11-19 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | N-methyl-4-{[trans-4-({[4-(trifluoromethoxy)phenyl]carbamoyl}amino)cyclohexyl]oxy}benzamide |
|
| KDS | Name: | 4-[(quinolin-3-yl)methyl]-N-[4-(trifluoromethoxy)phenyl]piperidine-1-carboxamide | Formula: | C23 H22 F3 N3 O2 | SMILES: | c4c(ccc(NC(=O)N1CCC(CC1)Cc3cnc2ccccc2c3)c4)OC(F)(F)F | InChi: | InChI=1S/C23H22F3N3O2/c24-23(25,26)31-20-7-5-19(6-8-20)28-22(30)29-11-9-16(10-12-29)13-17-14-18-3-1-2-4-21(18)27-15-17/h1-8,14-16H,9-13H2,(H,28,30) | Definition date: | 2018-11-26 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | 4-[(quinolin-3-yl)methyl]-N-[4-(trifluoromethoxy)phenyl]piperidine-1-carboxamide |
|
| KJ1 | Name: | N-(8-amino-8-oxooctyl)nonanamide | Formula: | C17 H34 N2 O2 | SMILES: | C(CNC(CCCCCCCC)=O)CCCCCC(=O)N | InChi: | InChI=1S/C17H34N2O2/c1-2-3-4-5-8-11-14-17(21)19-15-12-9-6-7-10-13-16(18)20/h2-15H2,1H3,(H2,18,20)(H,19,21) | Definition date: | 2018-12-10 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | N-(8-amino-8-oxooctyl)nonanamide |
|
| QL7 | Name: | N-{2-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-(morpholin-4-yl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide | Formula: | C24 H27 F N6 O4 | SMILES: | C(F)(C(C)(C)O)CN1Cc2c(C1=O)cc(c(c2)NC(=O)c3cnn4c3nccc4)N5CCOCC5 | InChi: | InChI=1S/C24H27FN6O4/c1-24(2,34)20(25)14-30-13-15-10-18(19(11-16(15)23(30)33)29-6-8-35-9-7-29)28-22(32)17-12-27-31-5-3-4-26-21(17)31/h3-5,10-12,20,34H,6-9,13-14H2,1-2H3,(H,28,32)/t20-/m1/s1 | Definition date: | 2019-11-13 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | N-{2-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-(morpholin-4-yl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
| MKP | Name: | 3-(3-tert-butyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-6-yl)-4-methyl-N-(1,2-oxazol-3-yl)benzamide | Formula: | C21 H21 N5 O3 | SMILES: | c1c(ccc(c1c2cc3c(nc2)N(C(N3)=O)C(C)(C)C)C)C(Nc4ccon4)=O | InChi: | InChI=1S/C21H21N5O3/c1-12-5-6-13(19(27)24-17-7-8-29-25-17)9-15(12)14-10-16-18(22-11-14)26(20(28)23-16)21(2,3)4/h5-11H,1-4H3,(H,23,28)(H,24,25,27) | Definition date: | 2019-04-08 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | 3-(3-tert-butyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-6-yl)-4-methyl-N-(1,2-oxazol-3-yl)benzamide |
|
| CQO | Name: | 3-(2,7-dimethoxyacridin-9-yl)sulfanylpropan-1-amine | Formula: | C18 H20 N2 O2 S | SMILES: | COc1ccc2nc3ccc(OC)cc3c(SCCCN)c2c1 | InChi: | InChI=1S/C18H20N2O2S/c1-21-12-4-6-16-14(10-12)18(23-9-3-8-19)15-11-13(22-2)5-7-17(15)20-16/h4-7,10-11H,3,8-9,19H2,1-2H3 | Definition date: | 2019-05-14 | Last modified: | 2019-11-15 | Release date: | 2019-11-20 | Identifier: | 3-(2,7-dimethoxyacridin-9-yl)sulfanylpropan-1-amine |
|
| GV7 | Name: | 4-[(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)amino]phenol | Formula: | C12 H11 N5 O | SMILES: | n12c(cc(C)nc1ncn2)Nc3ccc(O)cc3 | InChi: | InChI=1S/C12H11N5O/c1-8-6-11(17-12(15-8)13-7-14-17)16-9-2-4-10(18)5-3-9/h2-7,16,18H,1H3 | Definition date: | 2018-06-01 | Last modified: | 2019-11-12 | Release date: | 2019-04-10 | Identifier: | 4-[(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)amino]phenol |
|
| FOZ | Name: | N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | Formula: | C20 H23 N7 O7 | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)NCC2N(C=O)C=3C(=O)N=C(NC=3NC2)N)CCC(=O)O | InChi: | InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13-/m0/s1 | Definition date: | 2011-09-12 | Last modified: | 2019-11-12 | Identifier: | N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid |
|
| G7V | Name: | 4-{[(2S,4R)-1-acetyl-2-methyl-6-(1H-pyrazol-3-yl)-1,2,3,4-tetrahydroquinolin-4-yl]amino}benzonitrile | Formula: | C22 H21 N5 O | SMILES: | c1c(nnc1)c4cc3C(Nc2ccc(C#N)cc2)CC(C)N(C(C)=O)c3cc4 | InChi: | InChI=1S/C22H21N5O/c1-14-11-21(25-18-6-3-16(13-23)4-7-18)19-12-17(20-9-10-24-26-20)5-8-22(19)27(14)15(2)28/h3-10,12,14,21,25H,11H2,1-2H3,(H,24,26)/t14-,21+/m0/s1 | Definition date: | 2018-05-14 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | 4-{[(2S,4R)-1-acetyl-2-methyl-6-(1H-pyrazol-3-yl)-1,2,3,4-tetrahydroquinolin-4-yl]amino}benzonitrile |
|
| G3J | Name: | 1-[(2S,4R)-4-[(2-chlorophenyl)amino]-2-methyl-6-(1H-pyrazol-3-yl)-3,4-dihydroquinolin-1(2H)-yl]ethan-1-one | Formula: | C21 H21 Cl N4 O | SMILES: | n1nccc1c3cc4C(Nc2c(cccc2)Cl)CC(C)N(C(C)=O)c4cc3 | InChi: | InChI=1S/C21H21ClN4O/c1-13-11-20(24-19-6-4-3-5-17(19)22)16-12-15(18-9-10-23-25-18)7-8-21(16)26(13)14(2)27/h3-10,12-13,20,24H,11H2,1-2H3,(H,23,25)/t13-,20+/m0/s1 | Definition date: | 2018-05-03 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | 1-[(2S,4R)-4-[(2-chlorophenyl)amino]-2-methyl-6-(1H-pyrazol-3-yl)-3,4-dihydroquinolin-1(2H)-yl]ethan-1-one |
|
| KS8 | Name: | fosinoprilat | Formula: | C23 H34 N O5 P | SMILES: | OC(=O)[CH]1C[CH](CN1C(=O)C[P](O)(=O)CCCCc2ccccc2)C3CCCCC3 | InChi: | InChI=1S/C23H34NO5P/c25-22(17-30(28,29)14-8-7-11-18-9-3-1-4-10-18)24-16-20(15-21(24)23(26)27)19-12-5-2-6-13-19/h1,3-4,9-10,19-21H,2,5-8,11-17H2,(H,26,27)(H,28,29)/t20-,21+/m1/s1 | Definition date: | 2019-06-19 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | (2~{S},4~{S})-4-cyclohexyl-1-[2-[oxidanyl(4-phenylbutyl)phosphoryl]ethanoyl]pyrrolidine-2-carboxylic acid |
|
| KSN | Name: | (2~{S})-2-[[(4~{S})-4-azanyl-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]pentanedioic acid | Formula: | C10 H16 N2 O7 | SMILES: | N[CH](CCC(=O)N[CH](CCC(O)=O)C(O)=O)C(O)=O | InChi: | InChI=1S/C10H16N2O7/c11-5(9(16)17)1-3-7(13)12-6(10(18)19)2-4-8(14)15/h5-6H,1-4,11H2,(H,12,13)(H,14,15)(H,16,17)(H,18,19)/t5-,6-/m0/s1 | Definition date: | 2019-06-20 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | (2~{S})-2-[[(4~{S})-4-azanyl-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]pentanedioic acid |
|
| K8D | Name: | 4-(methylamino)benzene-1,2-dicarboxylic acid | Formula: | C9 H9 N O4 | SMILES: | c1(cc(NC)ccc1C(O)=O)C(O)=O | InChi: | InChI=1S/C9H9NO4/c1-10-5-2-3-6(8(11)12)7(4-5)9(13)14/h2-4,10H,1H3,(H,11,12)(H,13,14) | Definition date: | 2018-11-08 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | 4-(methylamino)benzene-1,2-dicarboxylic acid |
|
| K8G | Name: | 4-nitrobenzene-1,2-dicarboxylic acid | Formula: | C8 H5 N O6 | SMILES: | C(O)(c1c(C(O)=O)ccc([N+](=O)[O-])c1)=O | InChi: | InChI=1S/C8H5NO6/c10-7(11)5-2-1-4(9(14)15)3-6(5)8(12)13/h1-3H,(H,10,11)(H,12,13) | Definition date: | 2018-11-08 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | 4-nitrobenzene-1,2-dicarboxylic acid |
|
| K8J | Name: | 4-fluorobenzene-1,2-dicarboxylic acid | Formula: | C8 H5 F O4 | SMILES: | c1(cc(ccc1C(O)=O)F)C(O)=O | InChi: | InChI=1S/C8H5FO4/c9-4-1-2-5(7(10)11)6(3-4)8(12)13/h1-3H,(H,10,11)(H,12,13) | Definition date: | 2018-11-08 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | 4-fluorobenzene-1,2-dicarboxylic acid |
|
| KAY | Name: | 4-methylbenzene-1,2-dicarboxylic acid | Formula: | C9 H8 O4 | SMILES: | C(c1cc(C)ccc1C(O)=O)(O)=O | InChi: | InChI=1S/C9H8O4/c1-5-2-3-6(8(10)11)7(4-5)9(12)13/h2-4H,1H3,(H,10,11)(H,12,13) | Definition date: | 2018-11-16 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | 4-methylbenzene-1,2-dicarboxylic acid |
|
| KHS | Name: | N-{2-[(2-chlorophenyl)sulfanyl]ethyl}-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]sulfonyl}propanamide | Formula: | C18 H18 Cl F3 N2 O3 S2 | SMILES: | Clc1ccccc1SCCNC(=O)C(C)(C)S(=O)(=O)c2ccc(cn2)C(F)(F)F | InChi: | InChI=1S/C18H18ClF3N2O3S2/c1-17(2,16(25)23-9-10-28-14-6-4-3-5-13(14)19)29(26,27)15-8-7-12(11-24-15)18(20,21)22/h3-8,11H,9-10H2,1-2H3,(H,23,25) | Definition date: | 2018-12-07 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | N-{2-[(2-chlorophenyl)sulfanyl]ethyl}-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]sulfonyl}propanamide |
|
| M8Z | Name: | 2-[(3~{S})-3-azanylpiperidin-1-yl]-4-[[3,5-bis(2-cyanopropan-2-yl)phenyl]amino]pyrimidine-5-carboxamide | Formula: | C24 H30 N8 O | SMILES: | CC(C)(C#N)c1cc(Nc2nc(ncc2C(N)=O)N3CCC[CH](N)C3)cc(c1)C(C)(C)C#N | InChi: | InChI=1S/C24H30N8O/c1-23(2,13-25)15-8-16(24(3,4)14-26)10-18(9-15)30-21-19(20(28)33)11-29-22(31-21)32-7-5-6-17(27)12-32/h8-11,17H,5-7,12,27H2,1-4H3,(H2,28,33)(H,29,30,31)/t17-/m0/s1 | Definition date: | 2019-10-08 | Last modified: | 2019-11-08 | Release date: | 2019-11-13 | Identifier: | 2-[(3~{S})-3-azanylpiperidin-1-yl]-4-[[3,5-bis(2-cyanopropan-2-yl)phenyl]amino]pyrimidine-5-carboxamide |
|